Elizabeth Bayliss
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chronic Disease | 30 | 2021 | 1674 | 4.810 |
Why?
| Deprescriptions | 8 | 2023 | 23 | 4.280 |
Why?
| Multiple Chronic Conditions | 11 | 2021 | 24 | 3.130 |
Why?
| Dementia | 7 | 2023 | 196 | 2.770 |
Why?
| Cognitive Dysfunction | 6 | 2023 | 299 | 2.700 |
Why?
| Primary Health Care | 21 | 2022 | 1573 | 2.680 |
Why?
| Comorbidity | 23 | 2018 | 1650 | 2.580 |
Why?
| Patient-Centered Care | 8 | 2021 | 505 | 2.200 |
Why?
| Patient Care Team | 9 | 2019 | 524 | 2.170 |
Why?
| Patient Portals | 4 | 2022 | 30 | 2.000 |
Why?
| Delivery of Health Care, Integrated | 6 | 2021 | 244 | 1.600 |
Why?
| Quality of Life | 16 | 2022 | 2354 | 1.550 |
Why?
| Health Status | 8 | 2019 | 791 | 1.520 |
Why?
| Physicians, Primary Care | 7 | 2019 | 248 | 1.480 |
Why?
| Aged | 57 | 2023 | 20249 | 1.430 |
Why?
| Safety-net Providers | 3 | 2021 | 109 | 1.380 |
Why?
| Delivery of Health Care | 8 | 2021 | 814 | 1.310 |
Why?
| Depressive Disorder | 4 | 2012 | 384 | 1.280 |
Why?
| Continuity of Patient Care | 4 | 2019 | 275 | 1.250 |
Why?
| Self Care | 6 | 2012 | 347 | 1.180 |
Why?
| Quality of Health Care | 4 | 2021 | 631 | 1.150 |
Why?
| Aged, 80 and over | 26 | 2023 | 6795 | 1.090 |
Why?
| Chronic Pain | 2 | 2022 | 214 | 1.070 |
Why?
| Mental Disorders | 6 | 2020 | 950 | 1.050 |
Why?
| Communication | 7 | 2022 | 731 | 1.030 |
Why?
| Female | 73 | 2023 | 63247 | 1.000 |
Why?
| Health Services | 2 | 2017 | 105 | 0.980 |
Why?
| Male | 72 | 2023 | 60403 | 0.970 |
Why?
| Attitude of Health Personnel | 5 | 2017 | 1029 | 0.960 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 2 | 2022 | 234 | 0.950 |
Why?
| Humans | 103 | 2023 | 117633 | 0.940 |
Why?
| Gastric Bypass | 2 | 2014 | 99 | 0.940 |
Why?
| Health Status Indicators | 2 | 2014 | 170 | 0.900 |
Why?
| Medication Adherence | 6 | 2022 | 553 | 0.880 |
Why?
| Patient Reported Outcome Measures | 4 | 2019 | 233 | 0.860 |
Why?
| Retrospective Studies | 29 | 2022 | 12331 | 0.860 |
Why?
| Cholinergic Antagonists | 2 | 2019 | 28 | 0.850 |
Why?
| Food Supply | 1 | 2021 | 54 | 0.840 |
Why?
| Health Plan Implementation | 2 | 2019 | 125 | 0.810 |
Why?
| Self Efficacy | 3 | 2019 | 354 | 0.790 |
Why?
| Mental Health Services | 3 | 2019 | 326 | 0.790 |
Why?
| Qualitative Research | 10 | 2021 | 856 | 0.740 |
Why?
| Advance Directives | 1 | 2020 | 73 | 0.740 |
Why?
| United States | 28 | 2022 | 12768 | 0.740 |
Why?
| Medicare Part D | 2 | 2010 | 24 | 0.740 |
Why?
| Cohort Studies | 17 | 2022 | 5112 | 0.710 |
Why?
| Documentation | 1 | 2020 | 167 | 0.690 |
Why?
| Delayed Diagnosis | 1 | 2018 | 79 | 0.690 |
Why?
| Practice Guidelines as Topic | 3 | 2021 | 1524 | 0.680 |
Why?
| Middle Aged | 37 | 2021 | 28659 | 0.670 |
Why?
| Health Services Needs and Demand | 3 | 2015 | 270 | 0.660 |
Why?
| Diabetic Neuropathies | 2 | 2016 | 94 | 0.660 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1419 | 0.660 |
Why?
| Hypolipidemic Agents | 3 | 2017 | 94 | 0.660 |
Why?
| Patient Acceptance of Health Care | 4 | 2021 | 686 | 0.640 |
Why?
| Specialization | 2 | 2017 | 125 | 0.640 |
Why?
| Time-to-Treatment | 1 | 2018 | 158 | 0.640 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2023 | 2031 | 0.610 |
Why?
| Healthcare Disparities | 2 | 2021 | 490 | 0.610 |
Why?
| Health Maintenance Organizations | 6 | 2012 | 111 | 0.600 |
Why?
| Patients | 2 | 2021 | 125 | 0.600 |
Why?
| Medicaid | 2 | 2022 | 404 | 0.590 |
Why?
| Patient Satisfaction | 4 | 2019 | 617 | 0.590 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1228 | 0.580 |
Why?
| Medically Uninsured | 1 | 2017 | 134 | 0.580 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1233 | 0.580 |
Why?
| Hypoglycemic Agents | 5 | 2019 | 1026 | 0.570 |
Why?
| Bariatric Surgery | 2 | 2015 | 162 | 0.560 |
Why?
| Adult | 30 | 2023 | 32118 | 0.550 |
Why?
| Pain Management | 2 | 2015 | 300 | 0.550 |
Why?
| Colorado | 12 | 2021 | 4401 | 0.550 |
Why?
| Caregivers | 9 | 2023 | 684 | 0.550 |
Why?
| Antihypertensive Agents | 5 | 2019 | 455 | 0.550 |
Why?
| Health Promotion | 1 | 2021 | 682 | 0.550 |
Why?
| Sickness Impact Profile | 2 | 2005 | 65 | 0.540 |
Why?
| Electronic Health Records | 3 | 2021 | 724 | 0.540 |
Why?
| Gastroplasty | 1 | 2014 | 25 | 0.540 |
Why?
| Surveys and Questionnaires | 17 | 2022 | 4842 | 0.530 |
Why?
| Focus Groups | 5 | 2020 | 376 | 0.520 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2015 | 119 | 0.520 |
Why?
| Diabetes Mellitus | 7 | 2017 | 963 | 0.510 |
Why?
| Health Services Accessibility | 3 | 2017 | 798 | 0.510 |
Why?
| Hypertension | 7 | 2019 | 1202 | 0.500 |
Why?
| Neuralgia | 1 | 2015 | 144 | 0.500 |
Why?
| Drug Utilization | 2 | 2012 | 181 | 0.500 |
Why?
| Laparoscopy | 2 | 2014 | 395 | 0.490 |
Why?
| Morbidity | 2 | 2012 | 262 | 0.490 |
Why?
| Postoperative Care | 1 | 2015 | 229 | 0.490 |
Why?
| Hospitalization | 5 | 2022 | 1774 | 0.490 |
Why?
| Colorectal Neoplasms | 3 | 2014 | 624 | 0.480 |
Why?
| Socioeconomic Factors | 7 | 2020 | 1163 | 0.480 |
Why?
| Comparative Effectiveness Research | 1 | 2014 | 140 | 0.480 |
Why?
| Sleep Deprivation | 1 | 2015 | 183 | 0.470 |
Why?
| Telemedicine | 2 | 2019 | 595 | 0.460 |
Why?
| Preoperative Care | 1 | 2015 | 323 | 0.460 |
Why?
| Morphine | 1 | 2013 | 191 | 0.450 |
Why?
| Osteoarthritis | 3 | 2008 | 173 | 0.440 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2012 | 42 | 0.440 |
Why?
| Referral and Consultation | 1 | 2017 | 671 | 0.430 |
Why?
| Cross-Sectional Studies | 13 | 2023 | 4630 | 0.430 |
Why?
| Cluster Analysis | 2 | 2020 | 476 | 0.420 |
Why?
| Polypharmacy | 5 | 2023 | 74 | 0.420 |
Why?
| International Classification of Diseases | 1 | 2012 | 130 | 0.420 |
Why?
| Quality Improvement | 5 | 2020 | 940 | 0.410 |
Why?
| Antidepressive Agents | 1 | 2012 | 203 | 0.410 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 397 | 0.410 |
Why?
| Psychotherapy | 1 | 2012 | 176 | 0.400 |
Why?
| Office Visits | 3 | 2018 | 95 | 0.400 |
Why?
| Severity of Illness Index | 3 | 2015 | 2884 | 0.400 |
Why?
| Obesity | 2 | 2014 | 2711 | 0.390 |
Why?
| Physician-Patient Relations | 6 | 2019 | 506 | 0.390 |
Why?
| Prostatic Neoplasms | 2 | 2014 | 977 | 0.390 |
Why?
| Multimorbidity | 2 | 2021 | 21 | 0.380 |
Why?
| Neoplasms | 3 | 2014 | 2139 | 0.380 |
Why?
| Patient Preference | 3 | 2022 | 174 | 0.380 |
Why?
| Models, Statistical | 1 | 2014 | 656 | 0.370 |
Why?
| Analgesics, Opioid | 2 | 2014 | 759 | 0.370 |
Why?
| Vaccination Refusal | 2 | 2021 | 70 | 0.370 |
Why?
| Perception | 3 | 2020 | 313 | 0.370 |
Why?
| Patient Participation | 5 | 2022 | 362 | 0.370 |
Why?
| Stakeholder Participation | 2 | 2020 | 66 | 0.360 |
Why?
| Delphi Technique | 4 | 2018 | 145 | 0.360 |
Why?
| Emergency Service, Hospital | 3 | 2015 | 1819 | 0.350 |
Why?
| Research | 3 | 2018 | 445 | 0.350 |
Why?
| Health Personnel | 3 | 2019 | 552 | 0.350 |
Why?
| Self Report | 4 | 2022 | 715 | 0.340 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 327 | 0.340 |
Why?
| Risk Assessment | 7 | 2020 | 3208 | 0.340 |
Why?
| Health Services for the Aged | 1 | 2008 | 79 | 0.330 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 623 | 0.320 |
Why?
| Disease Progression | 2 | 2015 | 2541 | 0.320 |
Why?
| Geriatrics | 1 | 2008 | 79 | 0.320 |
Why?
| Medicare | 5 | 2022 | 720 | 0.320 |
Why?
| Cost of Illness | 2 | 2008 | 291 | 0.310 |
Why?
| Breast Neoplasms | 1 | 2018 | 1929 | 0.310 |
Why?
| Kidney Diseases | 1 | 2011 | 421 | 0.300 |
Why?
| Psychometrics | 3 | 2018 | 690 | 0.300 |
Why?
| Accidental Falls | 2 | 2019 | 164 | 0.290 |
Why?
| Potentially Inappropriate Medication List | 2 | 2022 | 11 | 0.290 |
Why?
| Telephone | 2 | 2017 | 158 | 0.280 |
Why?
| Parents | 3 | 2021 | 1163 | 0.270 |
Why?
| Cardiovascular Diseases | 2 | 2014 | 1717 | 0.260 |
Why?
| Pain Measurement | 2 | 2018 | 527 | 0.260 |
Why?
| Nomograms | 2 | 2014 | 51 | 0.260 |
Why?
| Single-Payer System | 1 | 2003 | 4 | 0.260 |
Why?
| Disease Management | 4 | 2017 | 603 | 0.260 |
Why?
| National Health Insurance, United States | 1 | 2003 | 6 | 0.260 |
Why?
| Patient Compliance | 1 | 2008 | 588 | 0.260 |
Why?
| Pragmatic Clinical Trials as Topic | 2 | 2022 | 45 | 0.260 |
Why?
| Death | 2 | 2022 | 99 | 0.250 |
Why?
| Dyslipidemias | 3 | 2019 | 158 | 0.250 |
Why?
| Vaccination | 3 | 2021 | 1143 | 0.250 |
Why?
| Managed Care Programs | 2 | 2014 | 159 | 0.250 |
Why?
| Multivariate Analysis | 5 | 2013 | 1584 | 0.240 |
Why?
| Health Services Research | 3 | 2017 | 379 | 0.240 |
Why?
| Insurance Coverage | 2 | 2018 | 219 | 0.230 |
Why?
| Health Care Reform | 1 | 2003 | 105 | 0.230 |
Why?
| Data Collection | 1 | 2005 | 667 | 0.230 |
Why?
| Interdisciplinary Communication | 2 | 2014 | 201 | 0.230 |
Why?
| Attitude | 2 | 2021 | 240 | 0.230 |
Why?
| Prognosis | 4 | 2014 | 3549 | 0.230 |
Why?
| Asthma | 2 | 2016 | 2016 | 0.230 |
Why?
| Survival Rate | 3 | 2014 | 1807 | 0.220 |
Why?
| Proxy | 1 | 2021 | 30 | 0.210 |
Why?
| Maryland | 1 | 2020 | 42 | 0.200 |
Why?
| Information Storage and Retrieval | 1 | 2021 | 120 | 0.200 |
Why?
| Patient Care Management | 1 | 2020 | 60 | 0.200 |
Why?
| Longitudinal Studies | 4 | 2018 | 2668 | 0.200 |
Why?
| Clergy | 1 | 2020 | 14 | 0.190 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.190 |
Why?
| Fee-for-Service Plans | 2 | 2014 | 94 | 0.190 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 167 | 0.190 |
Why?
| Residence Characteristics | 1 | 2022 | 290 | 0.190 |
Why?
| Age Factors | 6 | 2019 | 3223 | 0.190 |
Why?
| Health Surveys | 3 | 2012 | 485 | 0.190 |
Why?
| Southwestern United States | 1 | 2019 | 94 | 0.190 |
Why?
| Child, Preschool | 5 | 2021 | 9714 | 0.190 |
Why?
| Urban Health Services | 1 | 2019 | 68 | 0.180 |
Why?
| Interprofessional Relations | 2 | 2013 | 276 | 0.180 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 46 | 0.180 |
Why?
| Religion | 1 | 2019 | 72 | 0.180 |
Why?
| Follow-Up Studies | 4 | 2017 | 4911 | 0.180 |
Why?
| Comprehensive Health Care | 2 | 2017 | 22 | 0.180 |
Why?
| Attitude to Health | 2 | 2015 | 412 | 0.170 |
Why?
| Contraindications, Drug | 1 | 2018 | 8 | 0.170 |
Why?
| Mastectomy | 1 | 2018 | 111 | 0.170 |
Why?
| Time Factors | 5 | 2018 | 6906 | 0.170 |
Why?
| Radiotherapy, Adjuvant | 1 | 2018 | 186 | 0.170 |
Why?
| Vaccines | 2 | 2020 | 361 | 0.170 |
Why?
| Medical Informatics | 1 | 2019 | 98 | 0.170 |
Why?
| Interviews as Topic | 3 | 2016 | 614 | 0.170 |
Why?
| Chemotherapy, Adjuvant | 1 | 2018 | 342 | 0.160 |
Why?
| Young Adult | 6 | 2016 | 11077 | 0.160 |
Why?
| Independent Living | 1 | 2018 | 77 | 0.160 |
Why?
| SEER Program | 2 | 2014 | 198 | 0.160 |
Why?
| Models, Theoretical | 1 | 2021 | 595 | 0.160 |
Why?
| General Practice | 1 | 2016 | 25 | 0.150 |
Why?
| Case Management | 1 | 2017 | 64 | 0.150 |
Why?
| Electronics | 1 | 2017 | 69 | 0.150 |
Why?
| Blood Pressure | 3 | 2019 | 1680 | 0.150 |
Why?
| Influenza Vaccines | 1 | 2021 | 475 | 0.150 |
Why?
| Logistic Models | 5 | 2013 | 2018 | 0.150 |
Why?
| Adolescent | 6 | 2015 | 18902 | 0.150 |
Why?
| Body Mass Index | 2 | 2014 | 2076 | 0.150 |
Why?
| Schools | 1 | 2019 | 415 | 0.150 |
Why?
| Medication Therapy Management | 1 | 2017 | 78 | 0.150 |
Why?
| Patient Outcome Assessment | 1 | 2017 | 129 | 0.140 |
Why?
| Validation Studies as Topic | 1 | 2015 | 21 | 0.140 |
Why?
| Metformin | 1 | 2019 | 291 | 0.140 |
Why?
| Health Care Costs | 1 | 2019 | 410 | 0.140 |
Why?
| Influenza, Human | 1 | 2021 | 535 | 0.140 |
Why?
| Infant | 2 | 2021 | 8255 | 0.140 |
Why?
| Clinical Decision-Making | 1 | 2018 | 285 | 0.140 |
Why?
| Prospective Studies | 4 | 2022 | 6422 | 0.140 |
Why?
| Neoplasm Staging | 1 | 2018 | 1215 | 0.140 |
Why?
| Hyperlipidemias | 2 | 2012 | 144 | 0.130 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2022 | 685 | 0.130 |
Why?
| United States Agency for Healthcare Research and Quality | 1 | 2014 | 11 | 0.130 |
Why?
| Child | 5 | 2021 | 18649 | 0.130 |
Why?
| Research Design | 1 | 2020 | 968 | 0.130 |
Why?
| Proportional Hazards Models | 2 | 2015 | 1199 | 0.130 |
Why?
| Health Priorities | 1 | 2014 | 38 | 0.130 |
Why?
| Activities of Daily Living | 2 | 2008 | 386 | 0.120 |
Why?
| Health Education | 1 | 2016 | 342 | 0.120 |
Why?
| Cooperative Behavior | 2 | 2014 | 403 | 0.120 |
Why?
| Age Distribution | 1 | 2014 | 382 | 0.120 |
Why?
| Postoperative Complications | 2 | 2014 | 2113 | 0.120 |
Why?
| Risk Factors | 6 | 2023 | 9124 | 0.120 |
Why?
| Lung Diseases, Obstructive | 1 | 2012 | 58 | 0.120 |
Why?
| Terminally Ill | 1 | 2013 | 37 | 0.120 |
Why?
| Decision Making | 1 | 2019 | 806 | 0.120 |
Why?
| Postoperative Period | 1 | 2013 | 307 | 0.120 |
Why?
| Information Dissemination | 1 | 2014 | 184 | 0.110 |
Why?
| Depression | 3 | 2018 | 1196 | 0.110 |
Why?
| Guideline Adherence | 1 | 2017 | 538 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 870 | 0.110 |
Why?
| Obesity, Morbid | 1 | 2014 | 184 | 0.110 |
Why?
| Insulin | 2 | 2019 | 2138 | 0.110 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 355 | 0.100 |
Why?
| Secondary Prevention | 1 | 2013 | 255 | 0.100 |
Why?
| Diabetes Complications | 1 | 2013 | 226 | 0.100 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 137 | 0.100 |
Why?
| Data Mining | 1 | 2011 | 85 | 0.100 |
Why?
| Primary Prevention | 1 | 2013 | 218 | 0.100 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 98 | 0.100 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 202 | 0.100 |
Why?
| Databases, Factual | 2 | 2012 | 1145 | 0.090 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 724 | 0.090 |
Why?
| Weight Loss | 1 | 2015 | 711 | 0.090 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2013 | 235 | 0.090 |
Why?
| Prescription Fees | 1 | 2008 | 4 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 2948 | 0.090 |
Why?
| Poisson Distribution | 1 | 2008 | 75 | 0.090 |
Why?
| Medical Records Systems, Computerized | 2 | 2007 | 106 | 0.090 |
Why?
| Physicians | 1 | 2017 | 771 | 0.090 |
Why?
| Autoimmune Diseases | 1 | 2012 | 409 | 0.090 |
Why?
| Eligibility Determination | 1 | 2008 | 53 | 0.090 |
Why?
| Drug Utilization Review | 1 | 2008 | 63 | 0.090 |
Why?
| Self Disclosure | 1 | 2008 | 64 | 0.090 |
Why?
| Treatment Outcome | 4 | 2016 | 9353 | 0.080 |
Why?
| Community Health Services | 1 | 2010 | 212 | 0.080 |
Why?
| Pain | 1 | 2014 | 796 | 0.080 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.080 |
Why?
| Incidence | 2 | 2014 | 2504 | 0.080 |
Why?
| Biomedical Research | 1 | 2014 | 598 | 0.080 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 357 | 0.080 |
Why?
| Immunoglobulin G | 1 | 2012 | 786 | 0.080 |
Why?
| Treatment Refusal | 1 | 2007 | 91 | 0.080 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3258 | 0.080 |
Why?
| Sex Distribution | 1 | 2007 | 390 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 1038 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2012 | 698 | 0.070 |
Why?
| Urban Population | 2 | 2012 | 421 | 0.070 |
Why?
| Mass Screening | 1 | 2013 | 1081 | 0.070 |
Why?
| California | 2 | 2020 | 386 | 0.070 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1267 | 0.070 |
Why?
| Chicago | 1 | 2004 | 42 | 0.070 |
Why?
| Los Angeles | 1 | 2004 | 61 | 0.070 |
Why?
| Boston | 1 | 2004 | 69 | 0.070 |
Why?
| Linear Models | 1 | 2007 | 871 | 0.070 |
Why?
| Goals | 1 | 2005 | 148 | 0.060 |
Why?
| Algorithms | 1 | 2011 | 1550 | 0.060 |
Why?
| Social Support | 1 | 2007 | 555 | 0.060 |
Why?
| Self Concept | 1 | 2005 | 224 | 0.060 |
Why?
| Choice Behavior | 1 | 2005 | 176 | 0.060 |
Why?
| Medicine | 1 | 2004 | 102 | 0.060 |
Why?
| Regression Analysis | 1 | 2004 | 1072 | 0.050 |
Why?
| Cholesterol, LDL | 2 | 2014 | 310 | 0.050 |
Why?
| Washington | 1 | 2021 | 129 | 0.050 |
Why?
| Housing | 1 | 2022 | 117 | 0.050 |
Why?
| Insurance Claim Review | 1 | 2021 | 75 | 0.050 |
Why?
| Internet | 2 | 2019 | 656 | 0.050 |
Why?
| Health Care Rationing | 1 | 2020 | 53 | 0.050 |
Why?
| Resource Allocation | 1 | 2020 | 37 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2012 | 566 | 0.050 |
Why?
| Health Expenditures | 1 | 2022 | 189 | 0.050 |
Why?
| Assisted Living Facilities | 1 | 2020 | 12 | 0.050 |
Why?
| Medical Records | 1 | 2021 | 175 | 0.050 |
Why?
| Minority Groups | 1 | 2022 | 218 | 0.050 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 111 | 0.050 |
Why?
| Heart Failure | 1 | 2012 | 2029 | 0.050 |
Why?
| Social Determinants of Health | 1 | 2021 | 122 | 0.050 |
Why?
| Health Behavior | 1 | 2005 | 711 | 0.050 |
Why?
| Medicare Part C | 1 | 2019 | 17 | 0.040 |
Why?
| Nursing Homes | 1 | 2020 | 140 | 0.040 |
Why?
| Appointments and Schedules | 1 | 2019 | 74 | 0.040 |
Why?
| Mortality | 1 | 2020 | 317 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 835 | 0.040 |
Why?
| Intention | 1 | 2019 | 155 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 294 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 1149 | 0.040 |
Why?
| Fatigue | 1 | 2018 | 305 | 0.040 |
Why?
| Automation | 1 | 2016 | 79 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 1012 | 0.040 |
Why?
| Drug Interactions | 1 | 2017 | 372 | 0.040 |
Why?
| Guidelines as Topic | 1 | 2018 | 281 | 0.040 |
Why?
| Consensus | 1 | 2018 | 507 | 0.040 |
Why?
| Hospitals | 1 | 2020 | 540 | 0.040 |
Why?
| Prevalence | 1 | 2022 | 2438 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 553 | 0.030 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 319 | 0.030 |
Why?
| Pandemics | 1 | 2022 | 1155 | 0.030 |
Why?
| Patient Access to Records | 1 | 2013 | 14 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 498 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 499 | 0.030 |
Why?
| Electronic Mail | 1 | 2013 | 59 | 0.030 |
Why?
| Analysis of Variance | 2 | 2007 | 1451 | 0.030 |
Why?
| Remote Consultation | 1 | 2013 | 40 | 0.030 |
Why?
| Turkey | 1 | 2012 | 13 | 0.030 |
Why?
| Etanercept | 1 | 2012 | 51 | 0.030 |
Why?
| London | 1 | 2012 | 25 | 0.030 |
Why?
| Biomarkers | 2 | 2013 | 3574 | 0.030 |
Why?
| Infliximab | 1 | 2012 | 88 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 867 | 0.030 |
Why?
| Forecasting | 1 | 2014 | 371 | 0.030 |
Why?
| Needs Assessment | 1 | 2014 | 343 | 0.030 |
Why?
| Cross-Cultural Comparison | 1 | 2012 | 86 | 0.030 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 151 | 0.030 |
Why?
| United Kingdom | 1 | 2012 | 245 | 0.030 |
Why?
| Reoperation | 1 | 2013 | 554 | 0.030 |
Why?
| Immunologic Factors | 1 | 2012 | 230 | 0.020 |
Why?
| Antirheumatic Agents | 1 | 2012 | 241 | 0.020 |
Why?
| Models, Organizational | 1 | 2010 | 152 | 0.020 |
Why?
| Risk | 1 | 2012 | 926 | 0.020 |
Why?
| Sex Characteristics | 1 | 2014 | 681 | 0.020 |
Why?
| Empathy | 1 | 2010 | 128 | 0.020 |
Why?
| Aging | 1 | 2018 | 1690 | 0.020 |
Why?
| Veterans | 1 | 2017 | 989 | 0.020 |
Why?
| Holistic Health | 1 | 2007 | 6 | 0.020 |
Why?
| Patient Readmission | 1 | 2013 | 659 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1194 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1918 | 0.020 |
Why?
| CD-ROM | 1 | 2005 | 6 | 0.020 |
Why?
| Learning | 1 | 2010 | 392 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2005 | 80 | 0.020 |
Why?
| Nonlinear Dynamics | 1 | 2005 | 88 | 0.020 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 72 | 0.020 |
Why?
| Fruit | 1 | 2005 | 123 | 0.020 |
Why?
| Vegetables | 1 | 2005 | 121 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 155 | 0.020 |
Why?
| Registries | 1 | 2012 | 1969 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2005 | 720 | 0.010 |
Why?
| Exercise | 1 | 2005 | 1809 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|